SPONSOR
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
NCT06776770 Phase 1, Phase 2
Recruiting
A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer
Gastric Cancer
NCT06776757 Phase 1, Phase 2
Recruiting
Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer
Metastatic Colorectal Cancer